This Small Molecule Reverses Alzheimer's Disease Progression, Study Shows - podcast episode cover

This Small Molecule Reverses Alzheimer's Disease Progression, Study Shows

Feb 17, 202617 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

  • Nicotinamide adenine dinucleotide (NAD+) is central to cellular energy and mitochondrial health, driving redox reactions that produce ATP. Declining levels are linked to metabolic disorders, sarcopenia, and diabetes
  • Alzheimer's disease has strongly associated with disrupted NAD+ balance, and research suggests restoring intake can reverse cognitive decline rather than merely slowing disease progression
  • Animal studies show restoring NAD+ fully reversed advanced Alzheimer's features, including memory loss, inflammation, tau pathology, oxidative stress, and DNA damage, even after severe disease was established
  • NAD+ functions as an upstream regulator of brain resilience, coordinating energy production, DNA repair, inflammation control, and protein processing, reframing Alzheimer's as a systems-level energy failure
  • Practical strategies emphasize testing NAD+ status and supporting production safely via niacinamide alongside adequate intake of other B vitamins
For the best experience, listen in Metacast app for iOS or Android